chr1-62494430-A-G

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001367561.1(DOCK7):​c.5062T>C​(p.Leu1688=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.349 in 1,611,696 control chromosomes in the GnomAD database, including 100,413 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. L1688L) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.35 ( 9341 hom., cov: 32)
Exomes 𝑓: 0.35 ( 91072 hom. )

Consequence

DOCK7
NM_001367561.1 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.0270
Variant links:
Genes affected
DOCK7 (HGNC:19190): (dedicator of cytokinesis 7) The protein encoded by this gene is a guanine nucleotide exchange factor (GEF) that plays a role in axon formation and neuronal polarization. The encoded protein displays GEF activity toward RAC1 and RAC3 Rho small GTPases but not toward CDC42. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2012]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BP6
Variant 1-62494430-A-G is Benign according to our data. Variant chr1-62494430-A-G is described in ClinVar as [Benign]. Clinvar id is 585797.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.422 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
DOCK7NM_001367561.1 linkuse as main transcriptc.5062T>C p.Leu1688= synonymous_variant 40/50 ENST00000635253.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
DOCK7ENST00000635253.2 linkuse as main transcriptc.5062T>C p.Leu1688= synonymous_variant 40/505 NM_001367561.1 Q96N67-1

Frequencies

GnomAD3 genomes
AF:
0.347
AC:
52728
AN:
151932
Hom.:
9332
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.398
Gnomad AMI
AF:
0.417
Gnomad AMR
AF:
0.345
Gnomad ASJ
AF:
0.234
Gnomad EAS
AF:
0.185
Gnomad SAS
AF:
0.437
Gnomad FIN
AF:
0.274
Gnomad MID
AF:
0.297
Gnomad NFE
AF:
0.340
Gnomad OTH
AF:
0.305
GnomAD3 exomes
AF:
0.343
AC:
86169
AN:
250866
Hom.:
15615
AF XY:
0.346
AC XY:
46840
AN XY:
135550
show subpopulations
Gnomad AFR exome
AF:
0.400
Gnomad AMR exome
AF:
0.391
Gnomad ASJ exome
AF:
0.233
Gnomad EAS exome
AF:
0.196
Gnomad SAS exome
AF:
0.460
Gnomad FIN exome
AF:
0.283
Gnomad NFE exome
AF:
0.337
Gnomad OTH exome
AF:
0.313
GnomAD4 exome
AF:
0.349
AC:
509403
AN:
1459646
Hom.:
91072
Cov.:
36
AF XY:
0.351
AC XY:
254964
AN XY:
725840
show subpopulations
Gnomad4 AFR exome
AF:
0.394
Gnomad4 AMR exome
AF:
0.385
Gnomad4 ASJ exome
AF:
0.229
Gnomad4 EAS exome
AF:
0.168
Gnomad4 SAS exome
AF:
0.458
Gnomad4 FIN exome
AF:
0.284
Gnomad4 NFE exome
AF:
0.351
Gnomad4 OTH exome
AF:
0.338
GnomAD4 genome
AF:
0.347
AC:
52768
AN:
152050
Hom.:
9341
Cov.:
32
AF XY:
0.346
AC XY:
25689
AN XY:
74302
show subpopulations
Gnomad4 AFR
AF:
0.398
Gnomad4 AMR
AF:
0.345
Gnomad4 ASJ
AF:
0.234
Gnomad4 EAS
AF:
0.186
Gnomad4 SAS
AF:
0.438
Gnomad4 FIN
AF:
0.274
Gnomad4 NFE
AF:
0.340
Gnomad4 OTH
AF:
0.312
Alfa
AF:
0.345
Hom.:
4534
Bravo
AF:
0.352
Asia WGS
AF:
0.377
AC:
1313
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsApr 20, 2017- -
Benign, criteria provided, single submitterclinical testingGeneDxMar 14, 2021- -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Developmental and epileptic encephalopathy, 23 Benign:2
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabApr 11, 2023- -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
not specified Benign:1
Benign, criteria provided, single submitterclinical testingUnidad de Genómica Garrahan, Hospital de Pediatría GarrahanJul 15, 2024This variant is classified as Benign based on local population frequency. This variant was detected in 58% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy and Progressive Myoclonus Epilepsy. Number of patients: 54. Only high quality variants are reported. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.77
CADD
Benign
1.3
DANN
Benign
0.56
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs10889335; hg19: chr1-62960101; COSMIC: COSV52012440; COSMIC: COSV52012440; API